Published: May, 2017
The global cervical dysplasia market is considered as particularly consolidated in nature, with a presence of a scarce number of players holding a key share of the global market, states a research report by Transparency Market Research. In 2015, the prominent players in the global dysplasia market, including Hologic Inc., Qiagen AG, and F. Hoffmann-La Roche Ltd. held a share of 76% of the market and are anticipated to continue with this trend in the next few years. The increasing number of strategic collaborations with biotechnology and pharmaceutical companies is projected to encourage the growth of the global market throughout the forecast period. In addition, the increasing focus on research and development activities and the introduction of new therapeutics are estimated to encourage the market’s growth in the next few years.
According to the research study by Transparency Market Research, in 2015, the global market for cervical dysplasia was worth US$349.0 mn and is expected to reach a value of US$ 640.2 mn by the end of 2024. The market is estimated to register a healthy 7.0% CAGR between 2016 and 2024.
Increasing Technological Advancements to Fuel Growth in North America
In the last few years, North America held a major share of the global cervical dysplasia market. This region is anticipated to remain in the leading position throughout the forecast period, thanks to the developed healthcare infrastructure. The increasing awareness among patients regarding the technological advancements and screening programs for cervical dysplasia are expected to encourage the growth of the North America market in the next few years. In addition, the favorable reimbursement policies and the rising prevalence of cervical cancers are projected to accelerate the growth of the market in the coming years. Furthermore, Asia Pacific is anticipated to experience a strong growth in the next few years.
On the basis of diagnosis, the global market for cervical dysplasia has been categorized into diagnostic devices and diagnostic tests. In 2015, the diagnostic tests segment led and held a share of around 85% of the global cervical dysplasia market. According to the research report, this segment is estimated to remain in the leading position throughout the forecast period and register a strong growth. The increasing awareness among patients concerning cervical dysplasia is considered to augment the growth of this segment in the near future. Moreover, a substantial rise in the number of cervical cancer screening programs, particularly in developed economies is likely to accelerate the growth of this segment in the near future.
Favorable Government Policies to Accelerate Market Growth
The rising number of favorable government policies and the increasing awareness campaigns are the key factors likely to encourage the growth of the global cervical dysplasia market in the coming years. In addition, the rising number of cervical screening programs and the increasing funding by governments for cancer screening programs are predicted to supplement the market’s growth in the near future. Furthermore, innovations and technological advancements in the healthcare sector are likely to contribute extensively towards the overall development of the market in the next few years.
On the contrary, the low awareness among patients in underdeveloped economies is expected to restrict the growth of the global cervical dysplasia market throughout the forecast period. IN addition to this, the changes in the government policies and the HPV vaccination recommendations are projected to hamper the growth of the market in the near future. Nonetheless, the increasing geriatric population and the increasing prevalence of cervical cancers are estimated to generate growth opportunities for the market players in the next few years.
This information is based on the findings of a research report published by Transparency Market Research (TMR), titled “Cervical Dysplasia Market (Diagnostics - Diagnostic Tests (Pap Smear Test, HPV Test, Biopsy), Diagnostic Devices (Colposcopy); End User - Hospitals, Diagnostic Centers, Private Gynecologists’ Offices, Research and Academic Institutes, and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024.”
The global cervical dysplasia market has been segmented as below:
Global Cervical Dysplasia Market Revenue, by Diagnosis
- Diagnosis Test
- Pap Smear Test
- HPV Test
- Diagnostic Device
Global Cervical Dysplasia Market Revenue, by End User
- Diagnostic Centers
- Private Gynecologists’ Offices
- Research & Academic Institutes
- Ambulatory Surgical Centers
Global Cervical Dysplasia Market Revenue, by Geography
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453